Faecal Calprotectin and UCEIS Predict Short-term Outcomes in Acute Severe Colitis: Prospective Cohort Study

被引:62
作者
Jain, Saransh [1 ]
Kedia, Saurabh [1 ]
Bopanna, Sawan [1 ]
Sachdev, Vikas [1 ]
Sahni, Peush [2 ]
Dash, Nihar Ranjan [2 ]
Pal, Sujoy [2 ]
Vishnubhatla, Sreenivas [3 ]
Makharia, Govind [1 ]
Travis, Simon P. L. [4 ]
Ahuja, Vineet [1 ]
机构
[1] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
[2] All India Inst Med Sci, Dept Gastrointestinal Surg, New Delhi, India
[3] All India Inst Med Sci, Dept Biostat, New Delhi, India
[4] Oxford Univ Hosp, Translat Gastroenterol Unit, Oxford, England
关键词
Acute severe colitis; steroid failure; prediction; SEVERE ULCERATIVE-COLITIS; INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; C-REACTIVE PROTEIN; ENDOSCOPIC INDEX; INTRAVENOUS IMMUNOGLOBULIN; CLINICAL-COURSE; INFLIXIMAB; THERAPY; VALIDATION;
D O I
10.1093/ecco-jcc/jjx084
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Early objective markers for failure of intravenous[iv] corticosteroid for acute severe colitis [ASC] can avoid delay in rescue therapy or colectomy. We investigated faecal calprotectin [FC], C-reactive protein [CRP], and endoscopy using the ulcerative colitis endoscopic index of severity [UCEIS] as predictors of steroid failure following intensive therapy of ASC. Methods: Consecutive patients with ASC satisfying Truelove and Witts' criteria, hospitalised at a single centre from May 2015 to November 2016, were included; all received iv corticosteroids. The primary outcome measure was steroid failure defined as colectomy and/or rescue therapy with ciclosporin or infliximab during admission. FC levels were measured at admission and on Day 3 of intensive therapy. UCEIS was scored at admission, and CRP on Day 3 of intensive therapy. Results: Of 49 patients, 21 [43%] failed iv corticosteroids and 15 [31%] underwent surgery. FC levels were significantly higher in steroid failures (2522 [590-9654] mu g/g) compared with steroid responders (1530 [352-10 278] mu g/g) at admission [p = 0.04], as well as on Day 3 of iv corticosteroid therapy (2718 [222-9175] mu g/g vs 727 [218-4062] mu g/g, p = 0.001). Steroid failures had a higher median [range] UCEIS score than responders (6 [4-8] vs 5 [4-7] [p = 0.001]). CRP level did not differ significantly between steroid failures and responders. A UCEIS > 6 at admission and FC > 1000 mu g/g on Day 3 were independent predictors of steroid failure and need for rescue therapy/colectomy. Conclusions: All patients with UCEIS > 6 and Day 3 FC > 1000 mu g/g failed iv corticosteroids. The UCEIS score on admission and Day 3 FC are early predictors of failure of ivcorticosteroid therapy.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 34 条
[1]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[2]   Association Between the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and Outcomes in Acute Severe Ulcerative Colitis [J].
Corte, Crispin ;
Fernandopulle, Nilesh ;
Catuneanu, Ana Maria ;
Burger, Daniel ;
Cesarini, Monica ;
White, Lydia ;
Keshav, Satish ;
Travis, Simon .
JOURNAL OF CROHNS & COLITIS, 2015, 9 (05) :376-381
[3]   Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis [J].
De Vos, M. ;
Dewit, O. ;
D'Haens, G. ;
Baert, F. ;
Fontaine, F. ;
Vermeire, S. ;
Franchimont, D. ;
Moreels, T. ;
Staessen, D. ;
Terriere, L. ;
Vander Cruyssen, B. ;
Louis, E. .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (05) :557-562
[4]   Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis [J].
Dignass, Axel ;
Eliakim, Rami ;
Magro, Fernando ;
Maaser, Christian ;
Chowers, Yehuda ;
Geboes, Karel ;
Mantzaris, Gerassimos ;
Reinisch, Walter ;
Colombel, Jean-Frederic ;
Vermeire, Severine ;
Travis, Simon ;
Lindsay, James O. ;
Van Assche, Gert .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) :965-990
[5]   Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Publication with Expression of Concern) [J].
Dignass, Axel ;
Lindsay, James O. ;
Sturm, Andreas ;
Windsor, Alastair ;
Colombel, Jean-Frederic ;
Allez, Mathieu ;
D'Haens, Gert ;
D'Hoore, Andre ;
Mantzaris, Gerassimos ;
Novacek, Gottfried ;
Oeresland, Tom ;
Reinisch, Walter ;
Sans, Miquel ;
Stange, Eduard ;
Vermeire, Severine ;
Travis, Simon ;
Van Assche, Gert .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) :991-1030
[6]   The pattern and outcome of acute severe colitis [J].
Dinesen, Lotte C. ;
Walsh, Alissa J. ;
Protic, Marijana Nedeljkovic ;
Heap, Graham ;
Cummings, Fraser ;
Warren, Bryan F. ;
George, Bruce ;
Mortensen, Neil J. M. ;
Travis, Simon P. L. .
JOURNAL OF CROHNS & COLITIS, 2010, 4 (04) :431-437
[7]   COURSE AND PROGNOSIS OF ULCERATIVE COLITIS [J].
EDWARDS, FC ;
TRUELOVE, SC .
GUT, 1963, 4 (04) :299-+
[8]   Calprotectin, a faecal marker of organic gastrointestinal abnormality [J].
Fagerhol, MK .
LANCET, 2000, 356 (9244) :1783-1784
[9]   Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis [J].
Frin, Anne-Claire ;
Filippi, Jerome ;
Boschetti, Gilles ;
Flourie, Bernard ;
Drai, Jocelyne ;
Ferrari, Patricia ;
Hebuterne, Xavier ;
Nancey, Stephane .
DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) :11-16
[10]  
Gulati R, 1995, Trop Gastroenterol, V16, P19